NgospelMedia.Net
NgospelMedia.net is The No. 1 International Urban Gospel Media Website, The Largest Repository of Your Favorite Gospel Entertainment Website, Worldwide, Nigeria. We Published Latest Nigerian and Foreign Gospel Music Downloads, Videos; Lyrics, Artiste Biography, Daily Devotionals. NgospelMedia is mainly a Christian Website, as the Domain Name Speaks; Gospel; Which is also tagged as a Gospel On-line Ministry for Souls Winning... 

Pfizer’s COVID-19 pill could be ready later this year: report

0 86







- Advertisement -


A pill that’s being developed by Pfizer as a potential cure for COVID-19 could be ready later this year if the trials are successful, a report said.

The antiviral drug, PF-07321332, is designed to attack the “spine” of the SARS-CoV-2 virus to prevent it from replicating in the nose, throat and lungs, the Telegraph reported.

“We have designed PF-07321332 as a potential oral therapy that could be prescribed at the first sign of infection, without requiring that patients are hospitalized or in critical care,” Mikael Dolsten, who leads the company’s worldwide research, development and medical division, said in a statement.

Trials are already underway with volunteers between the ages of 18 and 60 in the US and Brussels, the newspaper reported.

Pfizer logo on building
Pfizer’s pill is designed to prevent the SARS-CoV-2 virus from replicating in the nose, throat, and lungs.
Getty Images

“If they have moved to this stage, they will be quietly optimistic,” Dr. Penny Ward, a visiting professor in pharmaceutical medicine at King’s College London, told the Telegraph.

Advertisements


Tablets and pills on blue background with surgical protective mask.
Pfizer’s COVID-19 pill would be prescribed at the first sign of infection.
Getty Images/iStockphoto

The drug company said the first phase of the trial is designed to look at how the drug is tolerated, in addition “significant side effects, and how people feel after taking it,” according to documents obtained by the newspaper.

The second phase will study how participants react to multiple doses, while the third will look at the impact of eating while on the drug, the outlet reported.

More trials would be needed to determine how the drug works with people infected with COVID-19, the newspaper reported.

A medical staff member prepares a dose of Pfizer/BioNTech COVID-19 vaccine.
A medical worker prepares a dose of Pfizer’s COVID-19 vaccine, which has proven to be 95 percent effective.
AFP via Getty Images

If the results of the trials are promising, the oral medication could be available later this year, the outlet reported.

Pfizer, along with its partner BioNTech, has already developed a COVID-19 vaccine that has been shown to be more than 95 percent effective.

Advertisements

Advertisements

- Advertisement -

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

- Advertisement -

- related posts -

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all Discussions

NgospelMedia.Net and its partners uses cookies and similar technology to collect and analyze data information about the users of this website. We use this information to enhance the content, advertising and other services available on the site. Accept Read More

0
Would love your thoughts, please comment.x
()
x




%d bloggers like this: